Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications drug utilization physician survey intron ® europe
JCA Development and Support We can be your expert partner for education and guidance throughout the whole development process including JCA impact on your product pipeline. We can help you with: JCA dossier and evidence refinement Post-submission support …
… a wide range of studies in the United States and Europe, including large observational burden-of-illness …
Infectious Disease Models Utilize the power of infectious disease models to inform your analyses and help you better understand the potential impact of your novel healthcare intervention. You rely on realistic disease models to understand and communicate …
… the use of administrative health care databases to conduct drug safety and background epidemiological research, …
Margaret Mayorga Patient-Centered Outcomes Assessment Telecommuter - USA MS, Biostatistics MPH, Epidemiology New York Medical College, New York, NY BS, Biology University of Scranton, Scranton, PA Margaret Mayorga, MS, MPH, is a Research Scientist in …
… and moderating focus groups with a variety of patient and physician populations and has experience managing large data …
… and electronic health data sources. Ms. Hoffman has led drug safety and effectiveness studies across several … and other key stakeholders in the United States (US) and Europe. Prior to joining RTI-HS, Ms. Hoffman worked as an … and has served as a reviewer for Pharmacoepidemiology and Drug Safety and other peer-reviewed journals. Ms. Hoffman …
… health care claims data, cross-sectional and longitudinal survey data, data from prospective clinical studies, data … in claims-based analyses to evaluate patterns and utilization implications of medication adherence among … and Persistence (ESPACOMP); International Congress on Drug Therapy in HIV Infection; the European AIDS conference; …
… Mr. Wolin spent 10 years in the pharmaceutical industry in drug safety and regulatory affairs. He has worked in a … therapy (autologous). Mr. Wolin has led numerous Food and Drug Administration meetings (pre-IND, end of phase 2, and …
… the US Department of Agriculture (USDA), US Food and Drug Administration (FDA), Centers for Disease Control and …